Avalo Therapeutics, Inc. (AVTX)
NASDAQ: AVTX · Real-Time Price · USD
17.35
+0.04 (0.23%)
At close: Mar 9, 2026, 4:00 PM EDT
17.31
-0.04 (-0.23%)
After-hours: Mar 9, 2026, 4:04 PM EDT

Avalo Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Mar '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Market Capitalization
320787471914,212
Upgrade
Market Cap Growth
265.40%965.79%-84.63%-75.15%-95.47%-77.67%
Upgrade
Enterprise Value
209-1-1521534,180
Upgrade
Last Close Price
17.317.439.101209.614895.967603.14
Upgrade
PS Ratio
1669.04176.293.792.6335.37628.78
Upgrade
PB Ratio
3.370.581.00-4.358.27171.49
Upgrade
P/TBV Ratio
3.950.63--22.11491.62
Upgrade
EV/Sales Ratio
1090.59--2.8728.36624.03
Upgrade
Debt / Equity Ratio
0.010.010.26-1.981.530.06
Upgrade
Net Debt / Equity Ratio
-1.21-1.00-0.75-0.78-0.83-0.71
Upgrade
Net Debt / EBITDA Ratio
1.683.280.24-0.280.240.38
Upgrade
Net Debt / FCF Ratio
2.132.720.18-0.320.270.43
Upgrade
Asset Turnover
0.000.010.070.320.090.17
Upgrade
Inventory Turnover
---896.212444.832074.05
Upgrade
Quick Ratio
14.0019.421.640.682.991.53
Upgrade
Current Ratio
14.2819.951.820.743.111.71
Upgrade
Return on Equity (ROE)
-174.79%-50.06%--684.77%-354.08%-282.65%
Upgrade
Return on Assets (ROA)
-37.18%-29.75%-53.91%-32.95%-82.82%-74.02%
Upgrade
Return on Invested Capital (ROIC)
--6834.61%--4261.92%-1501.54%-367.18%
Upgrade
Return on Capital Employed (ROCE)
-56.80%-28.40%-143.20%-266.10%-136.20%-165.80%
Upgrade
Earnings Yield
-31.11%-45.18%-432.43%-87.80%-44.19%-1.51%
Upgrade
FCF Yield
-16.31%-63.10%-422.75%-56.58%-37.19%-0.96%
Upgrade
Buyback Yield / Dilution
-450.90%-2599.19%-608.45%-8.32%-41.86%-28.52%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.